info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Press Releases » The Artificial Cornea and Corneal Implant Market to reach up to USD 642 million by 2028

The Artificial Cornea and Corneal Implant Market to reach up to USD 642 million by 2028


Published Date: Apr-2022 | Report Format:Electronic (PDF)

The report of "Artificial Cornea and Corneal Implant" Market by Type (Artificial Cornea and Human Cornea), By Implantation Type (Endothelial Keratoplasty, Penetrating Keratoplasty, and Others), By Disease manifestation (Keratoconus, Fungal Keratitis, Fuchs' Dystrophy, and Others), By End-User (Specialty Clinics & ASCs, and Hospitals) - Global Forecast to 2028. "The Global Artificial Cornea & Corneal Implant market share was accounted for approximately up to USD 421 million in 2020. It is most likely to reach about USD 642 million by 2028, along with a steady CAGR growth of around 6.90% throughout the anticipated time frame of 2020-2028. 

To know more about the report, Click on the link https://www.strategicmarketresearch.com/market-report/artificial-cornea-and-corneal-implant-market

 

Some of the most important factors propelling the market growth

The continuously increasing incidences of eye injuries, the scarce number of cornea donors, and corneal blindness are driving the growth of the market comprehensively. Each year, around 800,000 eye injuries occur at workplaces, along with almost 36,000 that require time off from work. But as per the Eye, Health & Safety Organization wearing proper eye protection equipment can prevent up to 90 % of all eye injuries.

 

By Type, the 'Human Cornea' segment held the highest portion of the share in 2020

Based on Type, the Artificial Cornea and Corneal Implant industry worldwide has been broadly bifurcated into Artificial Cornea and Human Cornea. The 'Human Cornea' dominated the market in all respects in 2020 with a steady CAGR growth because of the continuous spread of awareness regarding eye tissue donation and corneal implantations, particularly in emerging countries across the globe.

 

By Implantation Type, the Penetrating Keratoplasty segment accounted for up to the highest share of the market in 2020

Based on Implantation Type, the Global Artificial Cornea and Corneal Implant industry has been fragmented into Endothelial Keratoplasty, Penetrating Keratoplasty, and Others. The "Penetrating Keratoplasty" segment comprehensively dominated the market due to a continued rise in the number of patients with eye illnesses across the world, such as eyeball injury and infectious keratitis.

 

By Disease manifestation, the Fuchs' Dystrophy segment resulted in the maximum market share in 2020

Based on Disease manifestation, the Global Artificial Cornea and Corneal Implant industry has been fragmented into Keratoconus, Fungal Keratitis, Fuchs' Dystrophy, and Others. The "Fuchs' Dystrophy" segment comprehensively dominated the market due to the continuous surge in the number of Eye related diseases & increased awareness among people across the globe regarding the early detection of the condition.

 

By End-User, the Specialty Clinics & ASCs segment held most of the market share in 2020

Based on End-User, the Global Artificial Cornea and Corneal Implant industry has been fragmented into Specialty Clinics & ASCs, and Hospitals. The "Specialty Clinics & ASCs" dominated the market respectively due to the declination of inpatient surgeries & the rise in preference for more and more minor invasive procedures around the entire world.

 

The North American sector continued its sheer dominance in 2020

North America' held the maximum part of the market share due to the region's increased acceptance of sophisticated medical technologies, the presence of highly developed healthcare infrastructures, & a diverse presence of several highly-skilled corneal implant manufacturers. 

 

Moreover, owing to the rising disposable income, large population base, and the increase in patient awareness of eye care, the Asia-Pacific region is predicted to grow at the fastest rate over the forecasted period. 

 

The most important players prevailing in the market:

Some of the essential players present in the Global Artificial Cornea and Corneal Implant include CorneaGen, LinkoCare Life Sciences AB, Addition Technology, Mediphacos, Florida Lions Eye Bank, Presbia plc, DIOPTEX GmbH, Cornea Biosciences, San Diego Eye Bank, Aurolab, etc.

 

Recent Developments: -

  • In June 2020, AJL Ophthalmic successfully acquired its CE Mark approval for launching the ENDO-K PRO. As a result, the end-users would easily access the company's portfolio once it gets approved.

 

  • In January 2020, Mediphacos announced its launching of the Keraring Intrastromal Corneal. Due to this initiative, the corporation will now have the ability to gain a much higher market share than before.

Choose License Type



$0
$0
$0
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: (+1) 315-636-4233
  • UK: (+44) 1622-370-614
  • IN: (+91) 826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved